Carrie Stalter in Peoria, Illinois

Home Illinois Peoria

Carrie Stalter has Nurse Practitioner as her primary medical specialty. Their primary office is: 5114 N Glen Park Place Rd in Peoria, Illinois.

They're a part of the: Osf Multi-specialty Group medical group which has around 1,532 members. You can call their office at 309-655-2431 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2010 (around 14 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Carrie N Stalter Office Phone and Directions

Carrie Stalter
Osf Multi-specialty Group
5114 N Glen Park Place Rd
Peoria, Illinois 61614
309-655-2431

Patient Ratings
Please rate your experience with Carrie Stalter below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 309-655-2431

Enter a starting address:

Healthcare Info for Carrie Stalter

Medical School: Sorry, her university is not listed
Graduation Year: 2010
The Primary Medical Specialty for Carrie Stalter is listed as: Nurse Practitioner
Approximate Years of Experience: 14
PAC (PECOS ID)#: 7012171101
NPI #: 1982914834
NPI Created On: 10/13/2010
NPI Last Updated Listed as: 10/13/2010
Primary Taxonomy Code: 363LF0000X
License Number:
209008382
Listed Gender: Female

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788894691

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30